Glyceronephosphate O‐acyltransferase as a hemochromatosis modifier gene: Another iron in the fire?

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|62|2|337-339

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.62, Iss.2, 2015-08, pp. : 337-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statin Therapy Alone and in Combination with an Acyl-CoA:Cholesterol O-Acyltransferase Inhibitor on Experimental Atherosclerosis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 1, 2008-03 ,pp. : 9-17

Karger

Access to resources Recommend Favorite

Genetic predisposition to iron overload: Prevalence and phenotypic expression of hemochromatosis‐associated HFE‐C282Y gene mutation

By Distante S.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 66, Iss. 2, 2006-04 ,pp. : 83-100

Informa Healthcare

Access to resources Recommend Favorite

Iron depletion with a novel apheresis system in patients with hemochromatosis

By  

TRANSFUSION, Vol. 55, Iss. 5, 2015-05 ,pp. : 996-1000

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevalence of Hemochromatosis Gene (HFE) Mutations in Greece

By  

Acta Haematologica, Vol. 109, Iss. 3, 2003-05 ,pp. : 137-140

Karger

Access to resources Recommend Favorite

Connexin37: a potential modifier gene of inflammatory disease

By Chanson Marc   Kwak Brenda  

Journal of Molecular Medicine, Vol. 85, Iss. 8, 2007-08 ,pp. : 787-795

Springer Publishing Company

Access to resources Recommend Favorite